EKOPAK NV (EKOP.BR) Fundamental Analysis & Valuation

EBR:EKOP • BE0974380124

Current stock price

4.42 EUR
+0.02 (+0.45%)
Last:

This EKOP.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EKOP.BR Profitability Analysis

1.1 Basic Checks

  • EKOP had negative earnings in the past year.
  • EKOP had a negative operating cash flow in the past year.
  • EKOP had negative earnings in each of the past 5 years.
  • EKOP had negative operating cash flow in 4 of the past 5 years.
EKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFEKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • EKOP has a worse Return On Assets (-10.96%) than 70.45% of its industry peers.
  • EKOP's Return On Equity of -35.86% is on the low side compared to the rest of the industry. EKOP is outperformed by 70.45% of its industry peers.
Industry RankSector Rank
ROA -10.96%
ROE -35.86%
ROIC N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
EKOP.BR Yearly ROA, ROE, ROICEKOP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

  • Looking at the Gross Margin, with a value of 28.12%, EKOP is doing worse than 72.73% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EKOP has declined.
  • The Profit Margin and Operating Margin are not available for EKOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
EKOP.BR Yearly Profit, Operating, Gross MarginsEKOP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EKOP.BR Health Analysis

2.1 Basic Checks

  • EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EKOP has about the same amount of shares outstanding.
  • The number of shares outstanding for EKOP has been increased compared to 5 years ago.
  • Compared to 1 year ago, EKOP has a worse debt to assets ratio.
EKOP.BR Yearly Shares OutstandingEKOP.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M
EKOP.BR Yearly Total Debt VS Total AssetsEKOP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -0.05, we must say that EKOP is in the distress zone and has some risk of bankruptcy.
  • EKOP has a worse Altman-Z score (-0.05) than 72.73% of its industry peers.
  • EKOP has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
  • EKOP has a Debt to Equity ratio of 1.12. This is comparable to the rest of the industry: EKOP outperforms 40.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Altman-Z -0.05
ROIC/WACCN/A
WACC5.93%
EKOP.BR Yearly LT Debt VS Equity VS FCFEKOP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 0.82 indicates that EKOP may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.82, EKOP is doing worse than 70.45% of the companies in the same industry.
  • EKOP has a Quick Ratio of 0.82. This is a bad value and indicates that EKOP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.65, EKOP is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.65
EKOP.BR Yearly Current Assets VS Current LiabilitesEKOP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. EKOP.BR Growth Analysis

3.1 Past

  • The earnings per share for EKOP have decreased strongly by -239.72% in the last year.
  • EKOP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.41%.
  • Measured over the past years, EKOP shows a very strong growth in Revenue. The Revenue has been growing by 36.09% on average per year.
EPS 1Y (TTM)-239.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.69%
Revenue 1Y (TTM)-32.41%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-33.44%

3.2 Future

  • Based on estimates for the next years, EKOP will show a very strong growth in Earnings Per Share. The EPS will grow by 60.98% on average per year.
  • The Revenue is expected to grow by 25.77% on average over the next years. This is a very strong growth
EPS Next Y-81.63%
EPS Next 2Y14.29%
EPS Next 3Y24.69%
EPS Next 5Y60.98%
Revenue Next Year11.74%
Revenue Next 2Y19.97%
Revenue Next 3Y14.97%
Revenue Next 5Y25.77%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EKOP.BR Yearly Revenue VS EstimatesEKOP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EKOP.BR Yearly EPS VS EstimatesEKOP.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. EKOP.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EKOP. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EKOP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EKOP.BR Price Earnings VS Forward Price EarningsEKOP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EKOP.BR Per share dataEKOP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EKOP's earnings are expected to grow with 24.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.29%
EPS Next 3Y24.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EKOP.BR Dividend Analysis

5.1 Amount

  • No dividends for EKOP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EKOP.BR Fundamentals: All Metrics, Ratios and Statistics

EKOPAK NV

EBR:EKOP (3/26/2026, 7:00:00 PM)

4.42

+0.02 (+0.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-04
Earnings (Next)N/A
Inst Owners0.73%
Inst Owner ChangeN/A
Ins Owners83.15%
Ins Owner ChangeN/A
Market Cap77.35M
Revenue(TTM)36.74M
Net Income(TTM)-17.55M
Analysts42.22
Price Target5.61 (26.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)26.44%
PT rev (3m)26.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.11
P/FCF N/A
P/OCF N/A
P/B 1.58
P/tB 722.9
EV/EBITDA N/A
EPS(TTM)-1.09
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS2.1
BVpS2.8
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.96%
ROE -35.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.12%
FCFM N/A
ROA(3y)-4.22%
ROA(5y)-2.9%
ROE(3y)-12.98%
ROE(5y)-8.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.64%
GM growth 5Y-5.79%
F-Score1
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 176.27%
Cap/Sales 42.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.65
Altman-Z -0.05
F-Score1
WACC5.93%
ROIC/WACCN/A
Cap/Depr(3y)366.86%
Cap/Depr(5y)479.35%
Cap/Sales(3y)50.41%
Cap/Sales(5y)51.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-239.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-215.69%
EPS Next Y-81.63%
EPS Next 2Y14.29%
EPS Next 3Y24.69%
EPS Next 5Y60.98%
Revenue 1Y (TTM)-32.41%
Revenue growth 3Y61.78%
Revenue growth 5Y36.09%
Sales Q2Q%-33.44%
Revenue Next Year11.74%
Revenue Next 2Y19.97%
Revenue Next 3Y14.97%
Revenue Next 5Y25.77%
EBIT growth 1Y-306.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year418.18%
EBIT Next 3Y159.4%
EBIT Next 5Y139.97%
FCF growth 1Y-76.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.53%
OCF growth 3YN/A
OCF growth 5YN/A

EKOPAK NV / EKOP.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EKOPAK NV (EKOP.BR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to EKOP.BR.


Can you provide the valuation status for EKOPAK NV?

ChartMill assigns a valuation rating of 1 / 10 to EKOPAK NV (EKOP.BR). This can be considered as Overvalued.


What is the profitability of EKOP stock?

EKOPAK NV (EKOP.BR) has a profitability rating of 0 / 10.


How financially healthy is EKOPAK NV?

The financial health rating of EKOPAK NV (EKOP.BR) is 0 / 10.


Is the dividend of EKOPAK NV sustainable?

The dividend rating of EKOPAK NV (EKOP.BR) is 0 / 10 and the dividend payout ratio is 0%.